Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · January 17, 2024

Assessing the Prognostic Importance of Regression in Patients With Primary Cutaneous Melanoma Undergoing Sentinel Lymph Node Biopsy

Journal of the American Academy of Dermatology


Additional Info

Journal of the American Academy of Dermatology
Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A single-institutional cohort study
J Am Acad Dermatol 2023 Dec 01;[EPub Ahead of Print], NB Wagner, SM Knierim, F Luttermann, G Metzler, AS Yazdi, J Bauer, M Gassenmaier, A Forschner, U Leiter, T Amaral, C Garbe, TK Eigentler, S Forchhammer, L Flatz

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading